Raymond James Financial
FLGT icon

Raymond James Financial’s Fulgent Genetics FLGT Stock Holding History

Raymond James Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,473
Closed -$49.2K – 5581
2025
Q2 		$49.2K Buy
+2,473
New +$48.2K ﹤0.01% 5189

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James Financial's FLGT Position: Q3 2025 in Review

Raymond James Financial sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 2,473 shares — an estimated $49.2K sold.

Raymond James Financial first reported a position in FLGT in Q2 2025 and held it in 1 quarter. The position peaked at $49.2K in Q2 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Raymond James Financial reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 2,473 Fulgent Genetics shares in Q3 2025, an estimated $49.2K.
  • Raymond James Financial first reported a position in Fulgent Genetics in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Fulgent Genetics position peaked at $49.2K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.